| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 957,700 | 912,600 | 878,500 | 836,200 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 912,600 | 878,500 | 836,200 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,059,400 | 1,311,600 | 652,000 | 2,037,000 | | Non Recurring |
-
| (318,600) | 318,600 | (1,014,100) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (117,700) | (80,400) | (92,100) | (186,700) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (101,900) | (80,400) | (92,100) | (186,800) | | Interest Expense | 9,900 | 5,300 | 600 | 1,300 | | Income Before Tax | (111,800) | (85,700) | (92,700) | (188,100) | | Income Tax Expense | (65,500) | (69,800) | (38,800) | (61,500) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (46,300) | (15,900) | (53,900) | (126,500) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (46,200) | (15,900) | (53,900) | (126,500) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($46,200) | ($15,900) | ($53,900) | ($126,500) |
|
0.03% Nasdaq 0.00%
Income Statement
